RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer

Study ID
NCT02502656

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

RASANC

Trial Summary

This study will evaluate the concordance of RAS mutation detection between the results obtained from circulating tumor DNA and those obtained with the "standard" method (testing from tumor tissue).

More informations

Trial Starting Date

Jul 31,2015

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

425